Trial Profile
Intralesional Bevacizumab for Treating AIDS-associated Kaposi's Sarcoma of the Larynx, Pharynx and Oral Cavity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Antiretrovirals
- Indications Kaposi's sarcoma
- Focus Therapeutic Use
- 15 Feb 2011 New trial record